Suppr超能文献

血管活性肠肽(VIP)和肽-HI(PHI)对兔和猫血管舒张作用的比较。

Comparison of the vasodilatory effects of vasoactive intestinal polypeptide (VIP) and peptide-HI (PHI) in the rabbit and the cat.

作者信息

Nilsson S F, Mäepea O

出版信息

Acta Physiol Scand. 1987 Jan;129(1):17-26. doi: 10.1111/j.1748-1716.1987.tb08035.x.

Abstract

In rabbits, intravenous infusion of increasing doses of peptide-HI (PHI), with direct measurement of the uveal blood flow from a cannulated vortex vein, caused a dose-dependent decrease in the uveal vascular resistance. The maximal effect, a 50% decrease, was achieved with about 60 pmol kg-1 min-1. This is similar to what has previously been reported for vasoactive intestinal polypeptide (VIP). Determination of local blood flows, with radioactive microspheres, showed that i.v. infusion of VIP or PHI (60 pmol kg-1 min-1) caused about the same increase in the choroidal blood flow, while the local blood flow in the anterior uvea was unaffected by both peptides. The most marked effect of VIP was observed in glandular tissues, such as the pancreas, submandibular, parotid and thyroid glands. The pancreas was the only one of these tissues in which PHI caused an increased blood flow. In cats, i.v. infusion of VIP (30 pmol kg-1 min-1) during 5-7 min caused a markedly increased blood flow in several tissues. The vasodilation in glandular tissues was even more marked than in rabbits; 3-15 times the normal compared with two to five times the normal in rabbits. The choroidal blood flow was however significantly decreased and the local flow in the anterior uvea tended also to be reduced. Intravenous infusion of either a higher dose of VIP (60 pmol kg-1 min-1) or of PHI (1800 pmol kg-1 min-1) during 2 min had no effect on the uveal vascular resistance. This dose of PHI had only minor effects on local blood flows in other tissues. The results of the present study indicate that porcine VIP is a more potent vasodilator than porcine PHI in most tissues of both the cat and the rabbit, but that there may be exceptions such as the rabbit uvea. The difference in potency may also vary considerably between the species.

摘要

在兔子身上,通过插管涡静脉直接测量葡萄膜血流,静脉输注递增剂量的肽 - 组异肽(PHI),导致葡萄膜血管阻力呈剂量依赖性降低。最大效应是降低50%,在约60 pmol kg⁻¹ min⁻¹时达到。这与先前关于血管活性肠肽(VIP)的报道相似。用放射性微球测定局部血流表明,静脉输注VIP或PHI(60 pmol kg⁻¹ min⁻¹)使脉络膜血流增加大致相同,而两种肽对前葡萄膜局部血流均无影响。VIP最显著的作用见于腺组织,如胰腺、下颌下腺、腮腺和甲状腺。胰腺是这些组织中唯一PHI能使其血流增加的组织。在猫身上,静脉输注VIP(30 pmol kg⁻¹ min⁻¹)5 - 7分钟,导致多个组织血流显著增加。腺组织中的血管舒张比兔子身上更显著;与兔子身上是正常的两到五倍相比,猫身上是正常的3 - 15倍。然而,脉络膜血流显著减少,前葡萄膜局部血流也有减少趋势。静脉输注更高剂量的VIP(60 pmol kg⁻¹ min⁻¹)或PHI(1800 pmol kg⁻¹ min⁻¹)2分钟,对葡萄膜血管阻力无影响。该剂量的PHI对其他组织局部血流只有轻微影响。本研究结果表明,在猫和兔子的大多数组织中,猪VIP比猪PHI是更强效的血管舒张剂,但可能存在例外,如兔子的葡萄膜。效力差异在不同物种之间也可能有很大变化。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验